Showing results (1461-1470 of 3,473) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|November 20, 2013
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantationDennis A Hesselink, Rachida Bouamar, Laure Elens, et al.
Clinical Pharmacokinetics|December 12, 2013
Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspectiveKris M Jamsen, Sarah C McLeay, Michael A Barras, et al.
Clinical Pharmacokinetics|August 22, 2014
Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteersMargreke J E Brill, Anne van Rongen, Aletta P I Houwink, et al.
Clinical Pharmacokinetics|September 3, 2014
A review of the pharmacological properties of insulin degludec and their clinical relevanceHanne Haahr, Tim Heise
Clinical Pharmacokinetics|September 3, 2014
Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritisXia Chen, Yong Hou, Ji Jiang, et al.
Clinical Pharmacokinetics|August 27, 2014
Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysisMing Chang, Gunnel Tybring, Marja-Liisa Dahl, et al.
Clinical Pharmacokinetics|February 1, 1987
Clinical pharmacokinetic considerations in the use of plasma expandersU Klotz, H Kroemer
Clinical Pharmacokinetics|December 17, 2013
Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrugFabrice Balavoine, Michel Azizi, Damien Bergerot, et al.
Clinical Pharmacokinetics|August 29, 2015
Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic StudyDimitrios Alexopoulos, Nikolaos Barampoutis, Vasileios Gkizas, et al.
Clinical Pharmacokinetics|September 3, 2015
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV TherapyPrajakta S Badri, Jennifer R King, Akshanth R Polepally, et al.
Pageof 348